Role of inositol phospholipid signaling in natural killer cell biology

Frontiers in Immunology

Volumn 4, Issue MAR, 2013, Pages

  Gumbleton, Matthew ^a   Kerr, William G ^a,b,c  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b State University of New York Upstate Medical University: College of Medicine   (United States)

^c SYRACUSE UNIVERSITY   (United States)

Author keywords

IFN ; Inositol phospholipid; INPP4; Natural killer cells; PI3K; PIP5K; PTEN; SHIP

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; GAMMA INTERFERON; INTERLEUKIN 12; ISOENZYME; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PROTEIN; SH2 DOMAIN CONTAINING INOSITOL 5 PHOSPHATASE 1; SYNAPTOJANIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SURVIVAL; CHEMOTAXIS; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84883814728     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00047     Document Type: Article

References (102)

1. al-Aoukaty, A., Rolstad, B., and Maghazachi, A. A. (1999). Recruitment of pleckstrin and phosphoinositide 3-kinase gamma into the cell membranes, and their association with G beta gamma after activation of NK cells with chemokines. J. Immunol. 162, 3249-3255.
2. Alvarez Arias, D. A., Mccarty, N., Lu, L., Maldonado, R. A., Shinohara, M. L., and Cantor, H. (2010). Unexpected role of clathrin adaptor AP-1 in MHC-dependent positive selection of T cells. Proc. Natl. Acad. Sci. U.S.A. 107, 2556-2561.
3. Aoukaty, A., and Tan, R. (2002). Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J. Biol. Chem. 277, 13331-13337.
4. Arcaro, A., and Wymann, M. P. (1993). Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J. 296(Pt 2), 297-301.
5. Awasthi, A., Samarakoon, A., Dai, X., Wen, R., Wang, D., and Malarkannan, S. (2008). Deletion of PI3K-p85alpha gene impairs lineage commitment, terminal maturation, cytokine generation and cytotoxicity of NK cells. Genes Immun. 9, 522-535.
6. Badour, K., Zhang, J., Shi, F., Mcgavin, M. K., Rampersad, V., Hardy, L. A., et al. (2003). The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity 18, 141-154.
7. Banh, C., Miah, S. M., Kerr, W. G., and Brossay, L. (2012). Mouse natural killer cell development and maturation are differentially regulated by SHIP-1. Blood 120, 4583-4590.
8. Bao, Y., Zheng, J., Han, C., Jin, J., Han, H., Liu, Y., et al. (2012). Tyrosine kinase Btk is required for NK cell activation. J. Biol. Chem. 287, 23769-23778.
9. Barber, D. F., Faure, M., and Long, E. O. (2004). LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173, 3653-3659.
10. Barber, D. F., and Long, E. O. (2003). Coexpression of CD58 or CD48 with intercellular adhesion molecule 1 on target cells enhances adhesion of resting NK cells. J. Immunol. 170, 294-299.
11. Belanger, S., Tai, L. H., Anderson, S. K., and Makrigiannis, A. P. (2008). Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun. 9, 509-521.
12. Berridge, M. J., and Irvine, R. F. (1989). Inositol phosphates and cell signalling. Nature 341, 197-205.
13. Bhat, R., and Watzl, C. (2007). Serial killing of tumor cells by human natural killer cells - enhancement by therapeutic antibodies. PLoS ONE 2:e326. doi: 10.1371/journal.pone.0000326
14. Billadeau, D. D., Upshaw, J. L., Schoon, R. A., Dick, C. J., and Leibson, P. J. (2003). NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway. Nat. Immunol. 4, 557-564.
15. Bonnema, J. D., Karnitz, L. M., Schoon, R. A., Abraham, R. T., and Leibson, P. J. (1994). Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180, 1427-1435.
16. Brandstadter, J. D., and Yang, Y. (2011). Natural killer cell responses to viral infection. J. Innate Immun. 3, 274-279.
17. Briercheck, E., Trotta, R., Cole, J., Cole, T., Hartlage, A., Martin, C., et al. (2012). "Human natural killer (NK) cells: differential expression of phosphatase and tensin homologue deleted on chromosome ten (PTEN) during NK cell development regulates its cytolytic activity against leukemic target cells," in 54th ASH Annual Meeting and Exposition, Atlanta, GA.
18. Brooks, R., Fuhler, G. M., Iyer, S., Smith, M. J., Park, M. Y., Paraiso, K. H., et al. (2010). SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J. Immunol. 184, 3582-3589.
19. Bryceson, Y. T., Chiang, S. C., Darmanin, S., Fauriat, C., Schlums, H., Theorell, J., et al. (2011). Molecular mechanisms of natural killer cell activation. J. Innate Immun. 3, 216-226.
20. Calabia-Linares, C., Robles-Valero, J., De La Fuente, H., Perez-Martinez, M., Martin-Cofreces, N., Alfonso-Perez, M., et al. (2011). Endosomal clathrin drives actin accumulation at the immunological synapse. J. Cell Sci. 124, 820-830.
21. Cantley, L. C. (2002). The phosphoinositide 3-kinase pathway. Science 296, 1655-1657.
22. Capuano, C., Paolini, R., Molfetta, R., Frati, L., Santoni, A., and Galandrini, R. (2012). PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway. Blood 119, 2252-2262.
23. Carlin, L. M., Evans, R., Milewicz, H., Fernandes, L., Matthews, D. R., Perani, M., et al. (2011). A targeted siRNA screen identifies regulators of Cdc42 activity at the natural killer cell immunological synapse. Sci. Signal. 4, ra81.
24. Damen, J. E., Liu, L., Rosten, P., Humphries, R. K., Jefferson, A. B., Majerus, P. W., et al. (1996). The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc. Natl. Acad. Sci. U.S.A. 93, 1689-1693.
25. Di Paolo, G., Pellegrini, L., Letinic, K., Cestra, G., Zoncu, R., Voronov, S., et al. (2002). Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 gamma by the FERM domain of talin. Nature 420, 85-89.
26. Eissmann, P., Beauchamp, L., Wooters, J., Tilton, J. C., Long, E. O., and Watzl, C. (2005). Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood 105, 4722-4729.
27. Ferguson, K. M., Lemmon, M. A., Schlessinger, J., and Sigler, P. B. (1995). Structure of the high affinity complex of inositol trisphosphate with a phospholipase C pleckstrin homology domain. Cell 83, 1037-1046.
28. Ferron, M., Boudiffa, M., Arsenault, M., Rached, M., Pata, M., Giroux, S., et al. (2011). Inositol polyphosphate 4-phosphatase B as a regulator of bone mass in mice and humans. Cell Metab. 14, 466-477.
29. 2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 291, 1051-1055.
30. Fortenbery, N. R., Paraiso, K. H., Taniguchi, M., Brooks, C., Ibrahim, L., and Kerr, W. G. (2010). SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation. J. Immunol. 184, 5065-5074.
31. Fuhler, G. M., Brooks, R., Toms, B., Iyer, S., Gengo, E. A., Park, M. Y., et al. (2012). Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer. Mol. Med. 18, 65-75.
32. Galandrini, R., Micucci, F., Tassi, I., Cifone, M. G., Cinque, B., Piccoli, M., et al. (2005). Arf6: a new player in FcgammaRIIIA lymphocyte-mediated cytotoxicity. Blood 106, 577-583.
33. Galandrini, R., Tassi, I., Mattia, G., Lenti, L., Piccoli, M., Frati, L., et al. (2002). SH2-containing inositol phosphatase (SHIP-1) transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells. Blood 100, 4581-4589.
34. Gamper, N., and Shapiro, M. S. (2007). Target-specific PIP2 signalling: how might it work? J. Physiol. 582, 967-975.
35. Golebiewska, U., Nyako, M., Woturski, W., Zaitseva, I., and Mclaughlin, S. (2008). Diffusion coefficient of fluorescent phosphatidylinositol 4,5-bisphosphate in the plasma membrane of cells. Mol. Biol. Cell 19, 1663-1669.
36. Guo, H., Samarakoon, A., Vanhaesebroeck, B., and Malarkannan, S. (2008). The p110 delta of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation. J. Exp. Med. 205, 2419-2435.
37. Hamada, K., Shimizu, T., Matsui, T., Tsukita, S., and Hakoshima, T. (2000). Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J. 19, 4449-4462.
38. Hazen, A. L., Smith, M. J., Desponts, C., Winter, O., Moser, K., and Kerr, W. G. (2009). SHIP is required for a functional hematopoietic stem cell niche. Blood 113, 2924-2933.
39. Hinchliffe, K. A., Ciruela, A., and Irvine, R. F. (1998). PIPkins1, their substrates and their products: new functions for old enzymes. Biochim. Biophys. Acta 1436, 87-104.
40. Ishihara, H., Shibasaki, Y., Kizuki, N., Katagiri, H., Yazaki, Y., Asano, T., et al. (1996). Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase. J. Biol. Chem. 271, 23611-23614.
41. Itoh, T., Koshiba, S., Kigawa, T., Kikuchi, A., Yokoyama, S., and Takenawa, T. (2001). Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding and endocytosis. Science 291, 1047-1051.
42. Jiang, K., Zhong, B., Gilvary, D. L., Corliss, B. C., Hong-Geller, E., Wei, S., et al. (2000). Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat. Immunol. 1, 419-425.
43. Jiang, K., Zhong, B., Gilvary, D. L., Corliss, B. C., Vivier, E., Hong-Geller, E., et al. (2002). Syk regulation of phosphoinositide 3-kinase-dependent NK cell function. J. Immunol. 168, 3155-3164.
44. Jiang, K., Zhong, B., Ritchey, C., Gilvary, D. L., Hong-Geller, E., Wei, S., et al. (2003). Regulation of Akt-dependent cell survival by Syk and Rac. Blood 101, 236-244.
45. Johnson, C. M., Chichili, G. R., and Rodgers, W. (2008). Compartmentalization of phosphatidylinositol 4,5-bisphosphate signaling evidenced using targeted phosphatases. J. Biol. Chem. 283, 29920-29928.
46. Kanakaraj, P., Duckworth, B., Azzoni, L., Kamoun, M., Cantley, L. C., and Perussia, B. (1994). Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction. J. Exp. Med. 179, 551-558.
47. Kavanaugh, W. M., Pot, D. A., Chin, S. M., Deuter-Reinhard, M., Jefferson, A. B., Norris, F. A., et al. (1996). Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr. Biol. 6, 438-445.
48. Kawakami, Y., Kitaura, J., Satterthwaite, A. B., Kato, R. M., Asai, K., Hartman, S. E., et al. (2000). Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J. Immunol. 165, 1210-1219.
49. Kerr, W. G. (2011). Inhibitor and activator: dual functions for SHIP in immunity and cancer. Ann. N. Y. Acad. Sci. 1217, 1-17.
50. Kerr, W. G., and Colucci, F. (2011). Inositol phospholipid signaling and the biology of natural killer cells. J. Innate Immun. 3, 249-257.
51. Kerr, W. G., Heller, M., and Herzenberg, L. A. (1996). Analysis of lipopolysaccharide-response genes in B-lineage cells demonstrates that they can have differentiation stage-restricted expression and contain SH2 domains. Proc. Natl. Acad. Sci. U.S.A. 93, 3947-3952.
52. Kim, C. H., Hangoc, G., Cooper, S., Helgason, C. D., Yew, S., Humphries, R. K., et al. (1999). Altered responsiveness to chemokines due to targeted disruption of SHIP. J. Clin. Invest. 104, 1751-1759.
53. Kim, N., Saudemont, A., Webb, L., Camps, M., Ruckle, T., Hirsch, E., et al. (2007). The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion. Blood 110, 3202-3208.
54. Kishimoto, H., Ohteki, T., Yajima, N., Kawahara, K., Natsui, M., Kawarasaki, S., et al. (2007). The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. Blood 109, 3316-3324.
55. Lanier, L. L. (1998). NK cell receptors. Annu. Rev. Immunol. 16, 359-393.
56. Ling, K., Doughman, R. L., Firestone, A. J., Bunce, M. W., and Anderson, R. A. (2002). Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. Nature 420, 89-93.
57. Lioubin, M. N., Algate, P. A., Tsai, S., Carlberg, K., Aebersold, A., and Rohrschneider, L. R. (1996). p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10, 1084-1095.
58. Loijens, J. C., and Anderson, R. A. (1996). Type I phosphatidylinositol-4-phosphate 5-kinases are distinct members of this novel lipid kinase family. J. Biol. Chem. 271, 32937-32943.
59. Lowin-Kropf, B., and Held, W. (2000). Positive impact of inhibitory Ly49 receptor-MHC class I interaction on NK cell development. J. Immunol. 165, 91-95.
60. Lynch, E. D., Ostermeyer, E. A., Lee, M. K., Arena, J. F., Ji, H., Dann, J., et al. (1997). Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am. J. Hum. Genet. 61, 1254-1260.
61. Mace, E. M., Zhang, J., Siminovitch, K. A., and Takei, F. (2010). Elucidation of the integrin LFA-1-mediated signaling pathway of actin polarization in natural killer cells. Blood 116, 1272-1279.
62. Manilay, J. O., Waneck, G. L., and Sykes, M. (1999). Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level. J. Immunol. 163, 2628-2633.
63. Marti, F., Xu, C. W., Selvakumar, A., Brent, R., Dupont, B., and King, P. D. (1998). LCK-phosphorylated human killer cell-inhibitory receptors recruit and activate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U.S.A. 95, 11810-11815.
64. Martin, T. F. (2001). PI(4,5)P(2) regulation of surface membrane traffic. Curr. Opin. Cell Biol. 13, 493-499.
65. McLaughlin, S., and Murray, D. (2005). Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438, 605-611.
66. McLaughlin, S., Wang, J., Gambhir, A., and Murray, D. (2002). PIP(2) and proteins: interactions, organization, and information flow. Annu. Rev. Biophys. Biomol. Struct. 31, 151-175.
67. Micucci, F., Capuano, C., Marchetti, E., Piccoli, M., Frati, L., Santoni, A., et al. (2008). PI5KI-dependent signals are critical regulators of the cytolytic secretory pathway. Blood 111, 4165-4172.
68. Ming-Lum, A., Shojania, S., So, E., Mccarrell, E., Shaw, E., Vu, D., et al. (2012). A pleckstrin homology-related domain in SHIP1 mediates membrane localization during Fcgamma receptor-induced phagocytosis. FASEB J. 26, 3163-3177.
69. 3 phosphatase SHIP1. Nat. Cell Biol. 9, 36-44.
70. Ong, C. J., Ming-Lum, A., Nodwell, M., Ghanipour, A., Yang, L., Williams, D. E., et al. (2007). Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 110, 1942-1949.
71. Ono, M., Bolland, S., Tempst, P., and Ravetch, J. V. (1996). Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB. Nature 383, 263-266.
72. Orr, S. J., Quigley, L., and Mcvicar, D. W. (2009). In vivo expression of signaling proteins in reconstituted NK cells. J. Immunol. Methods 340, 158-163.
73. Parihar, R., Trotta, R., Roda, J. M., Ferketich, A. K., Tridandapani, S., Caligiuri, M. A., et al. (2005). Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Cancer Res. 65, 9099-9107.
74. Pesesse, X., Deleu, S., De Smedt, F., Drayer, L., and Erneux, C. (1997). Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem. Biophys. Res. Commun. 239, 697-700.
75. Pike, L. J., and Casey, L. (1996). Localization and turnover of phosphatidylinositol 4,5-bisphosphate in caveolin-enriched membrane domains. J. Biol. Chem. 271, 26453-26456.
76. Rak, G. D., Mace, E. M., Banerjee, P. P., Svitkina, T., and Orange, J. S. (2011). Natural killer cell lytic granule secretion occurs through a pervasive actin network at the immune synapse. PLoS Biol. 9:e1001151. doi: 10.1371/journal.pbio.1001151
77. Raulet, D. H., and Vance, R. E. (2006). Self-tolerance of natural killer cells. Nat. Rev. Immunol. 6, 520-531.
78. Rhee, S. G., and Bae, Y. S. (1997). Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272, 15045-15048.
79. Saito, K., Scharenberg, A. M., and Kinet, J. P. (2001). Interaction between the Btk PH domain and phosphatidylinositol-3,4,5-trisphosphate directly regulates Btk. J. Biol. Chem. 276, 16201-16206.
80. Saito, K., Tolias, K. F., Saci, A., Koon, H. B., Humphries, L. A., Scharenberg, A., et al. (2003). BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity 19, 669-678.
81. Saudemont, A., and Colucci, F. (2009). PI3K signaling in lymphocyte migration. Cell Cycle 8, 3307-3310.
82. Saudemont, A., Garcon, F., Yadi, H., Roche-Molina, M., Kim, N., Segonds-Pichon, A., et al. (2009). p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and disease. Proc. Natl. Acad. Sci. U.S.A. 106, 5795-5800.
83. Saudemont, A., Okkenhaug, K., and Colucci, F. (2007). p110delta is required for innate immunity to transplantable lymphomas. Biochem. Soc. Trans. 35, 183-185.
84. Scarpellino, L., Oeschger, F., Guillaume, P., Coudert, J. D., Levy, F., Leclercq, G., et al. (2007). Interactions of Ly49 family receptors with MHC class I ligands in trans and cis. J. Immunol. 178, 1277-1284.
85. Segovis, C. M., Schoon, R. A., Dick, C. J., Nacusi, L. P., Leibson, P. J., and Billadeau, D. D. (2009). PI3K links NKG2D signaling to a CrkL pathway involved in natural killer cell adhesion, polarity, and granule secretion. J. Immunol. 182, 6933-6942.
86. Tassi, I., Cella, M., Gilfillan, S., Turnbull, I., Diacovo, T. G., Penninger, J. M., et al. (2007). p110gamma and p110delta phosphoinositide 3-kinase signaling pathways synergize to control development and functions of murine NK cells. Immunity 27, 214-227.
87. Tokuyama, M., Lorin, C., Delebecque, F., Jung, H., Raulet, D. H., and Coscoy, L. (2011). Expression of the RAE-1 family of stimulatory NK-cell ligands requires activation of the PI3K pathway during viral infection and transformation. PLoS Pathog. 7:e1002265. doi: 10.1371/journal.ppat.1002265
88. Tolias K. F., Rameh, L. E., Ishihara, H., Shibasaki, Y., Chen, J., Prestwich, G. D., et al. (1998). Type I phosphatidylinositol-4-phosphate 5-kinases synthesize the novel lipids phosphatidylinositol 3,5-bisphosphate and phosphatidylinositol 5-phosphate. J. Biol. Chem. 273, 18040-18046.
89. Trotta, R., Parihar, R., Yu, J., Becknell, B., Allard, J. II, Wen, J., et al. (2005). Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood 105, 3011-3018.
90. Tu, Z., Ninos, J. M., Ma, Z., Wang, J. W., Lemos, M. P., Desponts, C., et al. (2001). Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein. Blood 98, 2028-2038.
91. Upshaw, J. L., Arneson, L. N., Schoon, R. A., Dick, C. J., Billadeau, D. D., and Leibson, P. J. (2006). NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells. Nat. Immunol. 7, 524-532.
92. Vanhaesebroeck, B., Guillermet-Guibert, J., Graupera, M., and Bilanges, B. (2010). The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell Biol. 11, 329-341.
93. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., et al. (2011). Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49.
94. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., and Ugolini, S. (2008). Functions of natural killer cells. Nat. Immunol. 9, 503-510.
95. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248.
96. Vyas, Y. M., Mehta, K. M., Morgan, M., Maniar, H., Butros, L., Jung, S., et al. (2001). Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J. Immunol. 167, 4358-4367.
97. Wahle, J. A., Paraiso, K. H., Costello, A. L., Goll, E. L., Sentman, C. L., and Kerr, W. G. (2006). Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets. J. Immunol. 176, 7165-7169.
98. Wahle, J. A., Paraiso, K. H., Kendig, R. D., Lawrence, H. R., Chen, L., Wu, J., et al. (2007). Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell. J. Immunol. 179, 8009-8015.
99. Wang, J. W., Howson, J. M., Ghansah, T., Desponts, C., Ninos, J. M., May, S. L., et al. (2002). Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation. Science 295, 2094-2097.
100. Wu, J., Song, Y., Bakker, A. B., Bauer, S., Spies, T., Lanier, L. L., et al. (1999). An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285, 730-732.
101. Yamanaka, Y., Tagawa, H., Takahashi, N., Watanabe, A., Guo, Y. M., Iwamoto, K., et al. (2009). Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 114, 3265-3275.
102. Zhong, B., Liu, J. H., Gilvary, D. L., Jiang, K., Kasuga, M., Ritchey, C. A., et al. (2002). Functional role of phosphatidylinositol 3-kinase in direct tumor lysis by human natural killer cells. Immunobiology 205, 74-94.